[ET Net News Agency, 24 August 2026] HANSOH PHARMA (03692) fell 2.6% to HK$32.22.
It hits an intra-day low of HK$32.08, dipping below the 20-D SMA of HK$32.847, and an intra-day high of HK$33.44. The total shares traded was 1.64 million, with a value of HK$53.47m. The active buy/sell ratio is 36:64, with net selling turnover of HK$14.28m. ABN AMRO CLEARING HK accounts for greatest net responsive buying turnover of HK$3.42m, with volume weighted average price of HK$32.729. BNP PARIBAS SEC (ASIA) accounts for greatest net responsive selling turnover of HK$1.44m, with volume weighted average price of HK$33.222. The stock has fallen a combined 4.3% over the past 2 consecutive trading days.
The Hang Seng Index now fell 418 points, or 1.6% to 25,590; the Hang Seng China Enterprises Index now fell 133 points, or 1.5% to 8,501.
Basic Information| Nominal | 32.220 | % Chg | -2.60% |
| High | 33.440 | Low | 32.080 |
| Shares Tr | 1.64m | Turnover | 53.47m |
| 10-D SMA | 33.312 | %H.V | 35.640 |
| 20-D SMA | 32.847 | VWAP | 32.677 |
| 50-D SMA | 31.893 | RSI14 | 46.505 |
Status: Dipping below the 20-D SMA, active buy/sell ratio is 36:64, with net selling turnover of HK$14.28m, falling a combined 4.3% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 32.220 | -2.60 |
| SIHUAN PHARM (00460) | 0.855 | -2.29 |
| GRAND PHARMA (00512) | 5.235 | -0.38 |
| SBP GROUP (01177) | 5.575 | -0.36 |
| HENGRUI PHARMA (01276) | 47.800 | -0.83 |
| LIVZON PHARMA (01513) | 21.000 | -15.73 |
| LUYE PHARMA (02186) | 2.105 | -2.55 |
| FOSUN PHARMA (02196) | 17.120 | -1.44 |
| SH PHARMA (02607) | 11.470 | -1.71 |
| CHINARES PHARMA (03320) | 4.715 | -1.98 |
(ed)
